NM_012080.5:c.43A>G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_012080.5(PUDP):​c.43A>G​(p.Met15Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000973 in 1,135,641 control chromosomes in the GnomAD database, including 1 homozygotes. There are 337 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00064 ( 0 hom., 23 hem., cov: 23)
Exomes 𝑓: 0.0010 ( 1 hom. 314 hem. )

Consequence

PUDP
NM_012080.5 missense

Scores

5
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.127

Publications

2 publications found
Variant links:
Genes affected
PUDP (HGNC:16818): (pseudouridine 5'-phosphatase) This gene encodes a member of the haloacid dehalogenase-like (HAD) hydrolase superfamily. The encoded protein has no known biological function. This gene has a pseudogene on chromosome 1. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2010]
STS (HGNC:11425): (steroid sulfatase) This gene encodes a multi-pass membrane protein that is localized to the endoplasmic reticulum. It belongs to the sulfatase family and hydrolyzes several 3-beta-hydroxysteroid sulfates, which serve as metabolic precursors for estrogens, androgens, and cholesterol. Mutations in this gene are associated with X-linked ichthyosis (XLI). Alternatively spliced transcript variants resulting from the use of different promoters have been described for this gene (PMID:17601726). [provided by RefSeq, Mar 2016]
MIR4767 (HGNC:41548): (microRNA 4767) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03861448).
BS2
High Hemizygotes in GnomAd4 at 23 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012080.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PUDP
NM_012080.5
MANE Select
c.43A>Gp.Met15Val
missense
Exon 1 of 4NP_036212.3Q08623-1
STS
NM_001320752.2
MANE Select
c.-146T>C
5_prime_UTR
Exon 1 of 11NP_001307681.2A0A590UJL0
PUDP
NM_001135565.2
c.43A>Gp.Met15Val
missense
Exon 1 of 5NP_001129037.1Q08623-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PUDP
ENST00000381077.10
TSL:1 MANE Select
c.43A>Gp.Met15Val
missense
Exon 1 of 4ENSP00000370467.6Q08623-1
STS
ENST00000674429.1
MANE Select
c.-146T>C
5_prime_UTR
Exon 1 of 11ENSP00000501534.1A0A590UJL0
PUDP
ENST00000424830.6
TSL:3
c.43A>Gp.Met15Val
missense
Exon 1 of 5ENSP00000396452.2Q08623-4

Frequencies

GnomAD3 genomes
AF:
0.000636
AC:
70
AN:
110091
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000656
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000283
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00298
Gnomad MID
AF:
0.00435
Gnomad NFE
AF:
0.000879
Gnomad OTH
AF:
0.000672
GnomAD2 exomes
AF:
0.000724
AC:
67
AN:
92530
AF XY:
0.000969
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00305
Gnomad NFE exome
AF:
0.000817
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00101
AC:
1035
AN:
1025498
Hom.:
1
Cov.:
28
AF XY:
0.000951
AC XY:
314
AN XY:
330224
show subpopulations
African (AFR)
AF:
0.000226
AC:
5
AN:
22159
American (AMR)
AF:
0.000118
AC:
3
AN:
25511
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17630
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24108
South Asian (SAS)
AF:
0.000126
AC:
6
AN:
47790
European-Finnish (FIN)
AF:
0.00324
AC:
120
AN:
37063
Middle Eastern (MID)
AF:
0.000503
AC:
2
AN:
3977
European-Non Finnish (NFE)
AF:
0.00108
AC:
865
AN:
804325
Other (OTH)
AF:
0.000792
AC:
34
AN:
42935
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
33
66
98
131
164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000636
AC:
70
AN:
110143
Hom.:
0
Cov.:
23
AF XY:
0.000703
AC XY:
23
AN XY:
32725
show subpopulations
African (AFR)
AF:
0.0000655
AC:
2
AN:
30533
American (AMR)
AF:
0.000283
AC:
3
AN:
10619
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2626
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3390
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2580
European-Finnish (FIN)
AF:
0.00298
AC:
17
AN:
5704
Middle Eastern (MID)
AF:
0.00478
AC:
1
AN:
209
European-Non Finnish (NFE)
AF:
0.000879
AC:
46
AN:
52316
Other (OTH)
AF:
0.000663
AC:
1
AN:
1508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000256
Hom.:
3
Bravo
AF:
0.000495
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000346
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000593
AC:
3
ExAC
AF:
0.000157
AC:
7

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.37
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
22
DANN
Benign
0.96
DEOGEN2
Benign
0.13
T
FATHMM_MKL
Benign
0.20
N
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.039
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
-0.13
PrimateAI
Uncertain
0.72
T
PROVEAN
Uncertain
-3.0
D
REVEL
Benign
0.13
Sift
Benign
0.034
D
Sift4G
Benign
0.11
T
Polyphen
0.12
B
Vest4
0.42
MVP
0.48
MPC
0.077
ClinPred
0.10
T
GERP RS
-0.31
PromoterAI
0.031
Neutral
Varity_R
0.65
gMVP
0.62
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374016250; hg19: chrX-7066112; API